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Abstract
Background: Staged excision and grafting with viable cryopreserved alloskin or fresh pigskin at an early stage is a
main strategy for wound management in massive burns. Alloskin is the gold standard of a biological temporary
skin substitute, and the main drawback to its wider use is the limited number of donors. In this paper, we compare
the use of fresh pigskins to cryopreserved alloskins as temporary skin substitutes on subcutaneous tissue wounds
after tangential excision by observing the clinical performances of these grafts in cases of a massive burn.
Methods: We selected six adult massive burn patients undergoing tangential excision and skin grafting on subcutaneous
tissue wounds (TESGSTW) at our burn center from January 1, 2003 to December 31, 2013. The general clinical data and
survival percentage of skins at postoperative weeks (POWs) 1, 2, and 3 were analyzed. In our clinical practice, we also
observed the phenomenon that several viable cryopreserved alloskin or fresh pigskin grafts used as temporary coverage
on subcutaneous tissue wounds had long-term survival after repeated desquamation. The macroscopic and histological
results of one typical case were also analyzed.
Results: In this study, the first three TESGSTW operations were performed at 2–3, 5–8, and 11–16 days post-injury. The
operation areas were 30.3 ± 7.9 % total body surface area (TBSA), 19.0 ± 6.0 % TBSA, and 12.0 ± 1.7 % TBSA, respectively.
The survival percentage of the cryopreserved alloskins or fresh pigskins at POWs 1, 2, and 3 were 80.0 ± 10.0 % vs 75.7 ±
5.3 % (t = 1.01, P = 0.16), 71.2 ± 10.6 % vs 66.4 ± 6.2 % (t = 1.09, P = 0.30), and 48.7 ± 2.5 % vs 35.0 ± 7.0 % (t = 3.83, P = 0.03),
respectively. The microscopic observation of the survival of alloskins or pigskins in one typical case showed rete ridges
and a basilar membrane at the joint of the epidermis and dermis at an early stage; these structures disappeared with
extended time post-operation.
Conclusions: From the clinical observations, fresh pigskin and cryopreserved alloskins could be used with equal
effectiveness at an early stage (within 2 weeks post-operation) as temporary coverage on massive burns after
TESGSTW. After engraftment, several cryopreserved alloskins or fresh pigskins could co-survive in a massive burn
patient for an extended amount of time. The co-survival of alloskin and pigskin will provide clues for further
research into skin transplantation.
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Background
The use of viable biological skins as temporary skin
substitutes to prepare the recipient wound after excision
for autografting is a lifesaving procedure in the manage-
ment of massive burns [1]. The common purpose of
viable alloskin and xenoskin is to act as a temporary bio-
logical dressing to accelerate the granulation and neo-
vascularization of the excised wound. Given the long
history of using alloskin and xenoskin as temporary skin
substitutes in burn care, the number of (comparative)
clinical trials is surprisingly small [2]. The purpose of
this article is to compare the clinical performance,
advantages, and disadvantages of using cryopreserved
alloskins with fresh pigskins as temporary skin substi-
tutes after tangential excision in a massive burn.
Since the 1970s, fascial excision has been successfully
performed in massive burn cases, resulting in decreased
hospital stays and mortality and reduced blood loss; these
grafts typically take well on the fascia [3]. The disadvantages
of fascial excision are lymphedema and contour deform-
ities. After the body-contouring adipose tissue is removed,
a very significant deformity results, particularly in the chests
of female patients [4].
To better preserve the body contouring and to decrease
lymphedema, since 1988, we have researched the use of
tangential excision for the management of wounds in
massive burns [5]. We perform tangential excisions down
to the level of viable adipose subcutaneous tissue; these
excisions are then covered by viable cryopreserved alloskins
or fresh pigskins for wound bed preparation. Subcutaneous
tissue wounds following tangential excision not only
contain relatively more bacteria and inflammatory edema
fluid but these tissues also have poor blood circulation,
which can easily result in the loss of the skin graft [6]. After
vascularization of reserved viable adipose tissue, auto-
skins (microskin or small stamps of skin) were grafted
for permanent healing. When autologous donor skin
was unavailable, viable alloskin or pigskin was still used
to cover all excised sites.
In our clinical practice, we have observed the
phenomenon that several viable, cryopreserved allo-
skin or fresh pigskin grafts could survive for extended
periods of time on the debrided wound and after re-
peated desquamation. The final clinical outcome and
histopathological observation of the long-term sur-
vival of cryopreserved alloskins or fresh pigskins post-
graft were analyzed in this paper.
From January 1, 2003 to December 31, 2013, six adult
massive burn cases receiving tangential excision and skin
grafting on subcutaneous tissue wound (TESGSTW) opera-
tions were selected, and grafts of viable cryopreserved
alloskins or fresh pigskins were used as temporary coverage.
The general clinical data we analyzed included the
operation times; operation areas; selection of coverage
on excision wounds; the survival percentage of the
grafted viable skins at postoperative weeks (POWs) 1,
2, and 3; long-term survival of the skin areas; macroscopic
observation; distribution of body positions; and survival
over at least 8 weeks. In a typical case, microscopic
observations were performed using hematoxylin and
eosin (H&E), Sirius red, and immunohistochemistry
staining of the grafted cryopreserved alloskins and fresh
pigskins with long-term survival after TESGSTW.
Methods
General clinical data
Six adult massive burn patients (four males, two females)
who underwent operation by TESGSTW between January
1, 2003, and December 31, 2013, were selected. After the
shock stage, the initial two or three TESGSTW operations
were performed on the limbs or trunk and were covered
with viable cryopreserved alloskins or fresh pigskins. The
areas excised in each operation were between 15 and 30 %
total body surface area (TBSA). Viable biological skins were
used as temporary skin substitutes to prepare the recipient
wound after excision for autografting. Autogenetic small
stamps of skin (approximately 0.5 cm× 0.5 cm) or micro-
skins were grafted for permanent healing at 2–4 weeks
post-tangential excision.
The viable cryopreserved cadaver skins were obtained
from the Weifang Medical College transplant bank
(Weifang, Shandong province). All donors were aged
20–50 and of Asian descent. The partial-thickness viable
cryopreserved skins were 0.4–0.5 mm thick. After cryo-
preservation in liquid nitrogen, the whole skins were
thawed in sterile physiological saline at 42 °C for 1 h be-
fore grafting.
According to our protocol, Yorkshire pigs weighing
50 kg and between 3 and 4 months in age were slaugh-
tered and full-thickness skin was excised in the morning
of the operation day. The harvested fresh pigskins were
washed with soap and water, and the hairs were shaved
with a razor blade. The fresh pigskins were scrubbed
with 0.1 % benzalkonium bromide solution for 15 min
and povidone-iodine solution for 5 min and were then
completely cleaned with sterile physiological saline three
times. The subdermal fat tissue and partial dermis were
removed using a dermatome, and 0.4–0.6 mm partial-
thickness skin was harvested for engraftment.
After limb or trunk tangential excision and hemostasis,
all wounds were covered with viable cryopreserved
cadaver skins and fresh pigskins. The plane of tangential
excision extended down to the level of viable subcutane-
ous adipose tissue. The analysis of the survival percent-
age of grafted viable skins at POWs 1, 2, and 3, the
survival of the skin areas % TBSA, macroscopic observa-
tions, and the distribution of body positions were
assessed for at least 8 weeks post-operation.
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The survival percentage of grafted viable skins = the
areas of the survival grafted skins/areas of the grafted
skins × 100 %.
In macroscopic observations, the standard used to
indicate the survival of grafted viable skins was that
the grafted skin was well-attached to the wound,
reddish or mildly purple in color, there were no
hematocele or empyema under the skin graft, or the
epidermis was separated from the dermis; if the
epidermis was well-attached to the underlying der-
mis, the dermis was not withered.
Histological observation of one typical case
In a typical case, microscopic observations using H&E,
Sirius red, and immunohistochemistry staining of cryo-
preserved alloskin or fresh pigskin grafts with long-term
survival after TESGSTW were also performed.
According to the consent of the ethics committee of
Jinan Central Hospital and the patients, biopsies for
histological examination were incised from the surviving
cryopreserved alloskins at 30, 50, and 96 days post-
engraftment. Biopsies for pathologic examination from
surviving fresh pigskins were incised at 25 and 71 days
post-engraftment. Biopsy of co-surviving alloskin and
pigskin grafts was incised on day 53 post-injury, with
alloskin 50 days post-engraftment and pigskin 25 days
post-engraftment on lower extremities. The junction of
co-surviving alloskin and pigskin grafts resulted by one
pigskin after another alloskin in two operations. The vi-
able alloskin was grafted on day 3 post-injury and fresh
pigskin was grafted on day 28 post-injury on the same
wound bed of lower extremity after debridement. These
biopsies (approximately 0.5 cm × 1.5 cm) were fixed in
10 % buffered neutral formaldehyde and embedded in
paraffin for histological analysis. The tissue sections were
stained with H&E and Sirius red (direct red 80) (Sigma-
Aldrich, USA) in picric acid. Immunohistochemistry
staining was performed for human cytokeratin 5/6 (CK
5/6) (Fuzhou Maixin Biotech, China). All samples were
photographed under a light microscope (IX71, Olympus,
Japan) to evaluate the dermis degeneration and reestab-
lishment of the epidermis in the surviving skin.
Statistical analysis
All data were expressed as the mean ± SD. The survival
percentage of grafted viable cryopreserved alloskins and
fresh pigskins at different POWs were tested using an
independent sample t test, the Levene test, and the t
test. All analyses were performed using SPSS software




The ages of the selected cases ranged 18–35 years old,
with an average age of 24.8 years old. Four patients were
male and two were female. The total burn areas and
full-thickness skin burn areas were 88.3 ± 5.7 % TBSA
and 81.6 ± 7.8 % TBSA, respectively.
Data from the TESGSTW operation
The TESGSTW operation time (post-injury), areas (%
TBSA), selection of wound coverage, the auto-skin grafting
time after TESGSTW operation (days), and the selection of
auto-skin type grafts after TESGSTW operations are shown
in Table 1. There were 15 TESGSTW operations performed
in total for the selected six cases at an early stage after burn.
The first TESGSTW operations were performed at 2–3 days
post-injury in six cases; these operations were performed
on the lower extremities in five cases and on the upper
extremities in one case. The areas excised in these six
operations were 30.3 ± 7.9 % TBSA, which were covered
with cryopreserved alloskins in four cases and with fresh
pigskins in two cases. The second TESGSTW operations
were performed at 5–8 days post-injury in six cases; these
operations were performed on the upper extremities and
Table 1 The TESGSTW operation time (days post-injury), areas (% TBSA), selection of coverage on wound, the auto-skin-grafted time





Post-injury (days) Operation sites (cases) Areas of excised
(% TBSA)







First (6) 2–3 Lower
extremities (5)
30.3 ± 7.9 Cryopreserved
alloskins (4),
fresh pigskins (2)
27.3 ± 3.8 Microskins (2), small
stamps of skin (4)
Second (6) 5–8 Upper lower
extremities
and (or) trunk (5)
19.0 ± 6.0 Cryopreserved
alloskins (2),
fresh pigskins (4)
22.0 ± 5.7 Microskins (1), small
stamps of skin (5)
Third (3) 11–16 Trunk (3) 12.0 ± 1.7 Cryopreserved
alloskins (2),
fresh pigskins (1)
15.3 ± 1.5 Small stamps of skin (3)
TESGSTW tangential excision and skin grafting on subcutaneous tissue wounds, TBSA total body surface area
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trunk in five cases and on the lower extremities in one case.
The areas excised in these six operations were 19.0 ± 6.0 %
TBSA, which were covered with cryopreserved alloskins in
two cases and fresh pigskins in four cases. The third
TESGSTW operations were performed at 11–16 days post-
injury in three cases. The operation sites were mainly on
the trunk. The excised areas were 12.0 ± 1.7 % TBSA, which
were covered with cryopreserved alloskins in two cases and
with fresh pigskins in one case. The extremities were
usually operated on at an early stage, and the trunk of the
body was operated on later.
The auto-skin-grafted time after the first, second, and
third TESGSTW operations to replace the grafted cryo-
preserved alloskins or fresh pigskins were 27.3 ± 3.8 days,
22.0 ± 5.7 days, and 15.3 ± 1.5 days, respectively. After
the first TESGSTW operations, the auto-skins were used
as microskins in two cases and small stamps of skin
were used in four cases to replace the cryopreserved
alloskin or fresh pigskin grafts. After the second
TESGSTW operations, the auto-skins were used as
microskins in one case and small stamps of skin were
used in five cases to replace the cryopreserved alloskin
or fresh pigskin grafts. After the third TESGSTW opera-
tions, small stamps of skin were used in all three cases.
Percentage of survival-viable skins at different POWs
The percentage of surviving viable skins at POWs 1, 2,
and 3 are shown in Table 2. Of these 15 TESGSTW
operations in a total of six selected cases, 8 operations
were covered with cryopreserved alloskins and 7 opera-
tions were covered with fresh pigskins. The areas covered
with either cryopreserved alloskins or fresh pigskins were
21.8 ± 10.9 % TBSA and 22.4 ± 8.5 % TBSA, respectively.
The survival percentage of the cryopreserved alloskins or
fresh pigskins at POWs 1, 2, and 3 were 80.0 ± 10.0 % vs
75.7 ± 5.3 % (t = 1.01, P = 0.16), 71.2 ± 10.6 % vs 66.4 ±
6.2 % (t = 1.09, P = 0.30), and 48.7 ± 2.5 % vs 35.0 ± 7.0 %
(t = 3.83, P = 0.03), respectively.
Areas and distribution of cryopreserved alloskins or fresh
pigskins with survival time over 8 weeks
The areas of cryopreserved alloskins or fresh pigskins
with survival times over 8 weeks were 2.0 ± 0.5 % TBSA
and 1.5 ± 0.2 % TBSA, respectively. The positions of the
survival skins were mainly on the lower extremities and
the ventrum. The grafts appeared to be “island” shaped,
with ruddy coloration or depigmentation, and with re-
peated desquamation.
Macroscopic and histological observation of one typical case
Macroscopic images of the lower extremities in a typical
massive burn case are shown in Fig. 1. The full-thickness
burn wound of the lower extremities and wound bed after
the TESGSTW operation is shown in Fig. 1a, b, respect-
ively. Macroscopic images of alloskin at POWs 1 and 2
are shown in Fig. 1c, d. A macroscopic image of the
surviving alloskin at 30 days post-graft is shown in Fig. 1e,
and the grafted fresh pigskin after debridement is shown
in Fig. 1f, and Fig. 1g shows long-term co-survival of allo-
skin and pigskin grafts on the lower extremities. An image
of the healed wounds on the lower extremities at an 8-
month follow-up is shown in Fig. 1h.
Figure 2 shows the histological observations made in
cryopreserved alloskins with long-term survival. A sec-
tion collected on day 30 was stained with H&E (Fig. 2a).
Allogenetic skin with a thickened epidermis that dis-
played hypergranulosis, prominent lymphocytic inflam-
matory cell infiltration of the dermis, and abundant
adipose tissue under the dermis could be observed. A
band of infiltrating lymphoid cells was observed between
the recipient’s wound bed and the grafted alloskin, as
shown in Fig. 2a. A section collected on day 50 was
stained with H&E (Fig. 2c). The rete ridges disappeared
into the epidermis, and the joint of the epidermis and
dermis (EDJ) was becoming smooth. By 96 days post-
engraftment, the degradation of collagen fibers was indi-
cated by the thinning of the collagen bundles of the
grafted dermis; these collagen fibers also became more
homogenous and were arranged in parallel, as shown in
Fig. 2e. The band of lymphocytic inflammatory cells dis-
appeared, and more spindle-shaped fibroblasts infiltrated
between the thinner collagen bundles. Immunochemistry
staining for human CK 5/6 showed positive expression
in the full epidermis, as shown in Fig. 2b, d, f. Figure 2b
also shows hypergranulosis in the epidermis of the
grafted after 30 days.
A pigskin section stained with H&E (Fig. 3a) also
showed hypergranulosis in the epidermis. The black
dotted line shown in Fig. 3a, b indicates the junction
of the co-surviving alloskin and pigskin grafts on day
53 post-injury, with alloskin 50 days post-engraftment
and pigskin 25 days post-engraftment. In Fig. 3a, the
pigskin graft is depicted on the right (R) and shows
incompletely degraded heavy-stained collagen bundles;
lymphocyte migration to the dermis and hypergranu-
losis in the epidermis can also be seen. To the left








Percentage of survival skins
1 week 2 weeks 3 weeks
Cryopreserved
alloskins (8)
21.8 ± 10.9 80.0 ± 10.0 71.2 ± 10.6 48.7 ± 2.5 %
Fresh pigskins (7) 22.4 ± 8.5 75.7 ± 5.3 66.4 ± 6.2 35.0 ± 7.0 %*
TESGSTW tangential excision and skin grafting on subcutaneous tissue
wounds, TBSA total body surface area, POWs postoperative weeks
*P < 0.05, as compared with cryopreserved alloskins
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(L) of the black line in Fig. 3b is the alloskin graft,
which shows incompletely degraded light-stained col-
lagen bundles.
A section collected on day 71 was stained with H&E
(Fig. 3c) and showed rete ridges disappearing into the
epidermis. The EDJ also became smoother. The collagen
bundles of the grafted dermis also became increasingly
homogenous, and more fibroblasts migrated to the gaps
between the collagen bundles. The adipose tissue under the
grafted pigskin is also shown in Fig. 3c. Immunochemistry
staining for human CK 5/6 showed positive expression in
the full epidermis, as shown in Fig. 3b, d.
Sirius red staining photomicrographs of the junction
between pig and human skin on day 53 post-injury, with
alloskin 50 days post-engraftment and pigskin 25 days
post-engraftment are shown in Fig. 4. Under polarized
light, type I collagen appeared as thick fibers with
strongly yellow or red birefringence. The grafted pig
dermis appeared more strongly birefringent than the ad-
jacent allogenetic dermis under polarized light (Fig. 4a).
Fig. 1 Macroscopic images of the lower extremities in a typical massive burn case. The full-thickness burn wound of the lower extremities is
shown in a. The wound beds of the lower extremities after the TESGSTW operation and before alloskin grafting are shown in b. Macroscopic
images of alloskin at POWs 1 and 2 are shown in c, d, respectively. A macroscopic image of the surviving alloskin on day 30 post-engraftment is
shown in e, and the grafted fresh pigskin after debridement is shown in f and g shows the long-term co-survival of alloskin and pigskin grafts on
the lower extremities 53 days post-injury, with alloskin 50 days post-engraftment and pigskin 25 days post-engraftment. An image of the healed
wounds on the lower extremities at an 8-month follow-up is shown in h
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Figure 4b shows the thick and undegraded pig collagen
bundles at a high-power view.
Discussion
Staged excision and coverage with viable cryopreserved
alloskins or fresh pigskins at an early stage is a main
strategy for the management of wounds in massive
burns [1]. In fascial excision, the skin and subcutaneous
tissue are removed, and the wound is debrided to the
level of the investing fascia. This approach is used in
cases of a massive burn to reduce blood loss or the risk
of a severe, life-threatening infection of the subcutane-
ous tissue [7]. Although the widespread use of fascia
excision in a massive burn both decreases hospital stays
and mortality, the long-term outcome and quality of life of
massive burn survivors are low due to the complications of
lymphedema and contour deformities [4]. Thus, in order to
enhance the quality of life and improve the mobility of the
healed wound, the viable subcutaneous tissue is used to
achieve a “bumper” effect. In tangential excision, the viable
subcutaneous fat and accompanying lymphatic tissue are
preserved, and excision is performed until the level of viable
subcutaneous tissue with a yellow glistening appearance is
reached. Autografting, such as the use of microskin or
small stamps of skin, do not take well on viable adipose
tissue before vascularization. However, viable cryopreserved
alloskins or fresh pigskins can be used as temporary skin
substitutes in order to vascularize the viable adipose tissue.
Since 1988, in order to better preserve the body con-
tours and decrease the incidence of lymphedema, we
have researched the use of tangential excision in the
management of wounds in massive burn cases [5]. The
TESGSTW operation includes tangential excision down
to the level of viable adipose tissue, temporarily covering
the wound with viable cryopreserved alloskin or fresh
pigskin and eventually grafting auto-skin (microskin or
Fig. 2 H&E (left) and immunochemistry staining (right) for human CK 5/6 of surviving cryopreserved alloskins on day 30 (upper), 50 (middle), and 96
(bottom) post-engraftment. The white dotted line in a shows a band of lymphoid cell infiltration between the recipient’s wound bed and the grafted
alloskin. c Arrowheads show the disappearing structures of rete ridges in the epidermis and the joint of the epidermis and dermis becoming smooth.
b, d, and f show immunochemistry staining for human CK 5/6; positive expression (arrows) can be observed in the full epidermis
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small stamps of skin) for permanent healing [6]. This
“sandwich technique” (also called the “Meek technique”
or the “micrografting technique”) could also be used for
wound closure in a massive burn. The use of viable
cryopreserved alloskins or fresh pigskin as temporary
coverage after excision is common in these techniques
before permanent healing of the wound in massive
burns, as this strategy uses the characteristics of viable
biological skins to “take” on the debrided wound bed.
Given the long history of using alloskin and xenoskin as
temporary skin substitutes in burn care, the number of
comparative clinical trials is surprisingly small [2].
Alloskin is the gold standard of a biological temporary
skin substitute that can adhere and become vascularized,
establishing vessel-to-vessel connection with the viable
wound bed [8, 9]. Cryopreserved alloskins are superior to
fresh donor skins in terms of availability, and they provide
sufficient time to accurately test the graft for septic contam-
ination [10]. When an alloskin graft adheres to the wound
bed and becomes vascularized, as indicated by bleeding
upon removal, the wound bed is considered ready for auto-
grafting [7, 11]. Cryopreserved alloskin can be vascularized
within 3–4 days post-graft and is rejected by the recipient
in approximately 2 to 3 weeks, although in rare instances,
Fig. 3 H&E (a, c) and immunochemistry staining (b, d) for human CK 5/6 of surviving fresh pigskins on day 25 (a, b) and 71 (c, d)
post-engraftment. The black dotted line shows a sharp dividing line between the pig dermis and the human dermis. c shows the
pigskin graft on day 71 post-engraftment; the arrow heads show the rete ridges disappearing in the epidermis, and the arrows show
the adipose tissue under the grafted pigskin. b and d show immunochemistry staining for human CK 5/6 with positive expression
(arrows) in the full epidermis
Fig. 4 Micrographs showing Sirius red staining of the junction between co-surviving pigskin and alloskin grafts on day 53 post-injury, with alloskin
50 days post-engraftment and pigskin 25 days post-engraftment. The white dotted line in a shows the sharp dividing line between the pig
dermis and the human dermis. b shows the thick and birefringent coallgen bundles of survival pigskin dermis on high-power view
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the alloskin is not rejected and is incorporated into the
recipient’s skin as a transplant [12].
Xenoskin, another option for temporary wound coverage,
can also become adherent and provides many benefits for
the covered wound, such as pain control. Although the
underlying wound bed undergoes granulation and neovas-
cularization, the xenoskin itself does not become vascular-
ized. From the early 1960s, a number of burn surgeons
started using pigskin as a biological dressing due to limited
resources of human alloskin [13]. In many countries, there
are no provisions of skin banks for cultural and ethical
reasons. Bromberg, in a study of 19 burn patients, reported
pigskin to be a suitable replacement for alloskin in terms of
the length of time it is used and its adherence [14]. Snyder-
man studied the survival of homografts and pigskin hetero-
grafts in patients with neoplastic disease, observing that
pigskin was retained for more than 7 days in 9 out of 10
patients [15]. A study by Brooklyn et al. showed that the
pigskin appeared soft and “viable” for nearly 3 weeks (mean
survival, 18 days) and then slowly dried and sloughed
during the next 2 weeks [14]. In summary, fresh pigskins
may become discolored, necrotic, and slough frequently at
10–14 days post-graft, leaving a clean, smooth, granulating
wound after being naturally autolyzed or debrided.
Thus, both alloskin and xenoskin are used for temporary
wound coverage in excised, non-grafted massive burns.
Various observers have attempted to compare the use of
alloskin to xenoskin as temporary skin covering. Appar-
ently, there is little difference in the effects of the two
procedures to clean a granulating area, prevent water and
protein losses, and decrease pain [2].
In this study, the macroscopic observations showed
that the reserved viable adipose tissues were glossy,
flexible, and had scattered bleeding points at 3–7 days
post-injury upon excision. When excised at 7–14 days
post-injury, the reserved viable adipose tissues were luteo-
testaceous, flexible, and had active bleeding. After
vascularization of the adipose tissue, the auto-skins were
grafted to cover the wounds after excision. In this study,
the first, second, and third TESGSTW operations were
performed at 2–3, 5–8, and 11–16 days post-injury,
respectively, and the areas undergoing the operations were
30.3 ± 7.9 % TBSA, 19.0 ± 6.0 % TBSA, and 12.0 ± 1.7 %
TBSA, respectively. The sites that were mainly on the
extremities were usually operated on at an early stage
(within 2 weeks post-injury), and the trunk of the body was
operated on later (within 3–4 weeks post-injury).
To replace the grafted cryopreserved alloskins or fresh
pigskins, the auto-skins were grafted after the first, second,
and third TESGSTW operations at 27.3 ± 3.8 days, 22.0 ±
5.7 days, and 15.3 ± 1.5 days, respectively. At those times,
with debridement of the wounds, the autografts took well
on the vascularized viable adipose tissue. The final healed
wounds had better body contouring and function, which
could be confirmed by microscopic observations of the vi-
able skins that showed long-term survival. The preserved
adipose tissues under the grafts are shown in Fig. 2a, b, d.
After alloskin or pigskin grafting, the wounds were
repeatedly evaluated either when the dressings were chan-
ged or when the patients underwent surgery again. In
cases of flaky necrosis or subcutaneous hydrops of the
alloskin or pigskin grafts, the grafts were removed in time
and replaced and then silver sulfadiazine was applied to
the wound. As shown in Fig. 1f, the fresh pigskin was
grafted onto the granulated wound for replacement. There
was no autologous skin placed underneath.
After vascularization of the adipose tissue, the auto-
skins (microskin or small stamps of skin) were grafted to
cover the wounds after excision. Macroscopic images of
small stamps of auto-skin and scrotum as donor site are
shown in Additional file 1: Figure S1. When small stamps
of skin were grafted for permanent wound healing, the
operative sites were dressed with mesh gauze impregnated
with antibiotic ointment, gauzes soaked in antibiotic solu-
tion, bulky dressing, and kept in the correct posture. The
dressing was first changed 5–7 days post-operation and
then once every 2 or 3 days from then on. The grafted au-
tologous microskin was overlain with a sheet of alloskin
(microskin grafting) and applied to the subcutaneous tis-
sue wound after the blood circulation had improved [6].
To prolong the survival time of the cryopreserved allo-
skin or fresh pigskin grafts on the wound bed, hemostasis
should be precisely maintained to avoid hematocele forma-
tion under the grafted viable skins. The dressings used to
fix the grafted skins should be compressed to avoid shifting
of the grafts. After the excisions to the viable adipose tissue,
viable cryopreserved alloskins were usually chosen for
temporary coverage at an early stage (within 2 weeks post-
injury) and fresh pigskins were used thereafter.
The transfer of human diseases via allografts, particularly
infections with viruses such as HIV, CMV, and hepatitis, is
a risk [16–18]. Alloskin availability is also limited by the
number of donors. Due to increasingly limited sources of
human alloskin, it is necessary to explore suitable, viable
temporary coverages in massive burns [19]. Fresh pigskin is
cheap and easy to use as a temporary dressing, though it
has more antigenicity and a higher rate of infection. In this
study, the survival percentages of cryopreserved alloskin
and fresh pigskin grafts at POWs 1 and 2 showed no
significant differences. At nearly 3 weeks after TESGSTW,
the cryopreserved alloskin or fresh pigskin grafts were
rejected or removed for immunological rejection and the
auto-skin transplantation operations were performed.
The clinical outcomes of grafted viable human or
pigskins as temporary substitutes could be summarized in
three ways: dissolution, necrosis, and desquamation. Dis-
solution of grafted alloskin or pigskin resulted in wound
reexposure, enhancing opportunities for infection. With
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living and expending of grafted autologous microskin or
small stamps of skin after Meek grafting or micrografting,
the blood supply of alloskin or pigskin will be blocked and
result in necrosis. Desquamation is the best type of clinical
outcome of grafted skins in terms of wound healing. The
phenomenon of repeated desquamation in the cryopre-
served alloskin or fresh pigskin grafts has been termed
“creeping substitution” by Brown and McDowell [20]. This
phenomenon has also been defined as “desquamation heal-
ing” by Zhang in China [21]. In this study, the areas of
cryopreserved alloskins or fresh pigskins with survival times
of over 8 weeks were 2.0 ± 0.5 % TBSA and 1.5 ± 0.2 %
TBSA, respectively. The positions of the surviving skins
were mainly on the lower extremities and the ventrum, and
the grafts appeared to be “island” shaped, with ruddy color-
ing or depigmentation, and with repeated desquamation.
The microscopic observation of the grafted human and
pigskins by H&E staining showed that both epidermises
had rete ridges. Over time, the EDJ became smoother, the
rete ridges were lost, and lymphocytes and fibroblasts mi-
grated into the gaps between collagen bundles in both graft
types. Moreover, the papillary and upper reticular dermis
was replaced with dense, relatively avascular homogenized
collagen. In 2006, the pathology working group of the Na-
tional Institute of Health Consensus Development pre-
sented the progression of histological changes from acute
to chronic cutaneous graft-versus-host disease (GVHD)
[22]. The minimal criterion for the diagnosis of cutaneous
sclerotic chronic GVHD is the homogenization of most of
the papillary dermis or reticular dermis. The skin can also
display a combination of residual damage, with the loss of
rete ridges and dermal appendages as well as some in-
creases in papillary or dermal sclerosis after immunosup-
pressive treatment [23].
At the junctions between grafted human and pigskins
that had co-survived long term, we could observe that
the pig dermis had thick and heavy-stained collagen
bundles compared to the grafted human dermis at an
early stage. The Sirius red staining showed an obvious
junction between the alloskins and pigskin. Immunohis-
tochemistry of the grafts showed positive expression of
human CK 5/6 in the reestablished epidermises of the
alloskins and pigskins. Whether the origin of the reestab-
lished epidermis in the human and pigskin grafts with
long-term survival is actually the patient can be determined
by DNA identification in future research. The results will
provide clues for further research of xenogenetic or allo-
genic skin transplantation.
For allogenic or xenogenic skin transplantation, immuno-
genicity is a major obstacle to prolonged use. For decreased
immunological rejection of the grafted fresh pigskins, some
pretreatments can be performed, such as ultraviolet irradi-
ation [24] or soaking in fluocinolone acetonide. The extra-
corporeal photochemotherapy (ECPCT) approach has a
complementary effect on preventing rejections with the
absence of the known side effects of conventional immuno-
suppression [25]. Pigs engineered to lack the gene for α-
1,3-galactosyltransferase (GTKO) became available for
experimental studies in 2002 [26]. The results of preclinical
transplantation of GTKO pig cells or corneas are much
more encouraging than those for organ transplantation,
with survival times of greater than 1 year [27]. Whether this
is also the case when the fresh skin of GTKO pigs is used
instead of alloskin as a skin temporary substitute remains
unclear. We can explore the use of engineered pigskins as
temporary substitutes to reduce immunological rejection
and prolong the survival time.
Conclusions
From the clinical observations, fresh pigskin was found
to be as effective as cryopreserved alloskins for use in
temporary coverage after TESGSTW for massive burns.
In the absence of available cadaver alloskin, fresh pigskin
is a satisfactory substitute for use as a temporary cover-
age. The co-survival of alloskin and pigskin will provide
clues for further research into allogenic and xenogenic
skin transplantation.
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